Reply to thread

Well when Saxenda was launched we were rolled up under the diabetes district.  Why not have both under one manager again? I mean primary care see both diabetes and obesity pts.  And quite honestly so do most weight loss physicians.  Pick your poison at this point: Wegovy, Ozempic or Rybelsus….depending on their diagnosis.  Either way the company is making money right?